Vertex Pharmaceuticals Incorporated vs UBS Group AG
Market cap comparison over time
Vertex Pharmaceuticals Incorporated
$133.4B
Rank #123
UBS Group AG
$139.9B
Rank #119
Market Cap Over Time
Key Moments
- Vertex Pharmaceuticals Incorporated overtook UBS Group AG by 2018
- UBS Group AG overtook Vertex Pharmaceuticals Incorporated by 2025
Year-by-Year Comparison
| Year | Vertex Pharmaceuticals Incorporated | UBS Group AG | Leader |
|---|---|---|---|
| 2026 | $133.4B | $139.9B | UBS Group AG |
| 2025 | $115.1B | $131.3B | UBS Group AG |
| 2024 | $102.2B | $94.7B | Vertex Pharmaceuticals Incorporated |
| 2023 | $103.3B | $86.7B | Vertex Pharmaceuticals Incorporated |
| 2022 | $73.3B | $55.5B | Vertex Pharmaceuticals Incorporated |
| 2021 | $55.7B | $51.4B | Vertex Pharmaceuticals Incorporated |
| 2020 | $60.0B | $38.1B | Vertex Pharmaceuticals Incorporated |
| 2019 | $55.6B | $35.0B | Vertex Pharmaceuticals Incorporated |
| 2018 | $42.1B | $33.2B | Vertex Pharmaceuticals Incorporated |
| 2017 | $38.0B | $46.8B | UBS Group AG |
| 2016 | $18.7B | $41.6B | UBS Group AG |
| 2015 | $31.9B | $48.1B | UBS Group AG |
| 2014 | $30.2B | $40.5B | UBS Group AG |
| 2013 | $18.9B | $39.6B | UBS Group AG |
| 2012 | $10.6B | $32.4B | UBS Group AG |
| 2011 | $8.4B | $25.2B | UBS Group AG |
| 2010 | $8.9B | $34.5B | UBS Group AG |
| 2009 | $10.9B | $36.7B | UBS Group AG |
| 2008 | $7.7B | $33.4B | UBS Group AG |
| 2007 | $5.9B | $117.9B | UBS Group AG |
| 2006 | $9.5B | $161.9B | UBS Group AG |
| 2005 | $7.0B | $136.7B | UBS Group AG |
| 2004 | $2.7B | $104.2B | UBS Group AG |
| 2003 | $2.6B | $92.6B | UBS Group AG |
| 2002 | $4.0B | $73.5B | UBS Group AG |
| 2001 | $6.2B | $91.6B | UBS Group AG |
| 2000 | $18.1B | $95.7B | UBS Group AG |
| 1999 | $4.4B | $77.8B | UBS Group AG |
| 1998 | $3.8B | $76.4B | UBS Group AG |
| 1997 | $4.2B | $76.2B | UBS Group AG |
| 1996 | $5.1B | $42.6B | UBS Group AG |
| 1995 | $3.4B | $47.6B | UBS Group AG |